In an 8-year-old boy with prolonged fever, maculopapular rash, conjunctival injection, and strawberry tongue who suffered a cardiac arrest and is now intubated, sedated, and supported with extracorporeal membrane oxygenation, what is the most critical post‑cardiac‑arrest care intervention?

Targeted Temperature Management to Prevent Fever >38°C

Start targeted temperature management to prevent temperature >38°C is the most critical post-cardiac arrest care intervention for this child. 1, 2

Clinical Context: Likely Kawasaki Disease with Cardiac Arrest

This 8-year-old presents with classic features of Kawasaki disease (12 days of fever, maculopapular rash, conjunctival injection, strawberry tongue) complicated by severe hypertension and cardiac arrest, suggesting coronary artery involvement with myocardial dysfunction. 1 The post-arrest management priorities must address both the underlying inflammatory condition and the post-cardiac arrest syndrome.

Why Temperature Management is Critical

Fever prevention is the single most important neuroprotective intervention after pediatric cardiac arrest. 1, 2 The 2024 International Consensus on Cardiopulmonary Resuscitation provides a strong recommendation to actively prevent fever by targeting temperature ≤37.5°C for patients who remain comatose after ROSC. 1 The 2019 AHA Pediatric Post-Cardiac Arrest Care guidelines emphasize that persistent hyperthermia is associated with unfavorable neurological outcomes in children. 1

Target Temperature Range

• Maintain central temperature ≤37.5°C (normothermia: 36-37.5°C) 1, 2
• Aggressively treat any temperature ≥38°C 1, 2
• The 2024 guidelines updated the duration recommendation to 36-72 hours of fever prevention for comatose patients 1

Evidence Base

The THAPCA trials (both out-of-hospital and in-hospital) demonstrated that therapeutic hypothermia at 32-34°C provides no benefit over normothermia at 36-37.5°C in pediatric cardiac arrest. 1, 2, 3 Therefore, the focus is on preventing hyperthermia rather than inducing hypothermia. 1, 2

Why Other Options Are Incorrect

Stress-Dose Corticosteroids

While this patient likely has Kawasaki disease requiring high-dose IVIG and aspirin, stress-dose corticosteroids are not a standard post-cardiac arrest intervention. 1 There is no guideline recommendation for routine corticosteroid administration in pediatric post-cardiac arrest care unless treating a specific underlying condition (e.g., adrenal insufficiency). 1

Hyperoxia with PaO₂ >300 mm Hg

Hyperoxia is harmful and should be avoided. 1 The 2019 AHA guidelines recommend titrating FiO₂ to maintain oxygen saturation 94-99% and targeting normal PaO₂ appropriate for the child's condition. 1 Post-cardiac arrest hyperoxia has been associated with worse outcomes in pediatric studies, though the evidence is inconsistent. 1

Tight Glucose Control 150-180 mg/dL

This target range is too narrow and potentially dangerous for pediatric patients. 1 The guidelines recommend monitoring and treating hypoglycemia, but there is no evidence supporting tight glucose control in pediatric post-cardiac arrest care. 1 Hypoglycemia must be avoided, but aggressive insulin therapy increases this risk. 1

Empiric Antibiotics

While infection surveillance is important, empiric broad-spectrum antibiotics are not a routine post-cardiac arrest intervention unless there is clinical suspicion of sepsis as the precipitating cause. 1 This patient's presentation is consistent with Kawasaki disease, not sepsis. The guidelines recommend treating the underlying cause of arrest, but antibiotics are not universally indicated. 1

Additional Critical Post-Arrest Interventions

Beyond temperature management, this patient requires:

• Hemodynamic optimization: Maintain age-appropriate blood pressure (avoid hypotension, which occurred in 56% of pediatric IHCA patients and was independently associated with mortality) 1
• Ventilation targets: Normoxia (SpO₂ 94-99%) and normocapnia (PaCO₂ 35-45 mm Hg) 1
• ECMO management: Continue support until myocardial recovery, with attention to anticoagulation and circuit monitoring 1
• Treatment of Kawasaki disease: High-dose IVIG and aspirin once stabilized 1
• Seizure monitoring: EEG monitoring for subclinical seizures 1

Implementation Details

Use a temperature control device with continuous core temperature monitoring (esophageal, rectal, or bladder probe) and feedback system. 1, 2 Surface or endovascular cooling methods are equally acceptable. 1 Administer antipyretics liberally (acetaminophen, ibuprofen) to maintain temperature ≤37.5°C, adding physical cooling measures if needed. 2

Common Pitfall

Do not allow fever to develop while focusing on other interventions. Temperature management must begin immediately and continue throughout the post-arrest period, as even brief episodes of hyperthermia worsen neurological outcomes. 1, 2 The patient is already on ECMO, which provides an excellent platform for precise temperature control. 1